UBS AM’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
149,178
-10,319
| -6% | -$78K | ﹤0.01% | 2360 |
|
|
2025
Q1 | $880K | Sell |
159,497
-232
| -0.1% | -$1.28K | ﹤0.01% | 2363 |
|
|
2024
Q4 | $918K | Sell |
159,729
-10,886
| -6% | -$62.6K | ﹤0.01% | 2402 |
|
|
2024
Q3 | $1.77M | Sell |
170,615
-27,597
| -14% | -$286K | ﹤0.01% | 2101 |
|
|
2024
Q2 | $2.57M | Sell |
198,212
-9,877
| -5% | -$128K | ﹤0.01% | 1861 |
|
|
2024
Q1 | $3.63M | Sell |
208,089
-15,980
| -7% | -$279K | ﹤0.01% | 1401 |
|
|
2023
Q4 | $2.11M | Sell |
224,069
-55,153
| -20% | -$519K | ﹤0.01% | 1666 |
|
|
2023
Q3 | $3.12M | Sell |
279,222
-10,852
| -4% | -$121K | ﹤0.01% | 1414 |
|
|
2023
Q2 | $11.7M | Hold |
290,074
| – | – | 0.01% | 909 |
|
|
2023
Q1 | $11.7M | Sell |
290,074
-4,088
| -1% | -$165K | 0.01% | 909 |
|
|
2022
Q4 | $13.7M | Buy |
294,162
+266,993
| +983% | +$12.4M | 0.01% | 844 |
|
|
2022
Q3 | $1.41M | Hold |
27,169
| – | – | ﹤0.01% | 1778 |
|
|
2022
Q2 | $1.28M | Buy |
27,169
+8,510
| +46% | +$402K | ﹤0.01% | 1829 |
|
|
2022
Q1 | $1.33M | Buy |
18,659
+4,979
| +36% | +$354K | ﹤0.01% | 1996 |
|
|
2021
Q4 | $1.02M | Buy |
13,680
+1,349
| +11% | +$101K | ﹤0.01% | 2200 |
|
|
2021
Q3 | $701K | Hold |
12,331
| – | – | ﹤0.01% | 2338 |
|
|
2021
Q2 | $543K | Sell |
12,331
-1,206
| -9% | -$53.1K | ﹤0.01% | 2507 |
|
|
2021
Q1 | $668K | Buy |
13,537
+6,907
| +104% | +$341K | ﹤0.01% | 2281 |
|
|
2020
Q4 | $279K | Sell |
6,630
-4,485
| -40% | -$189K | ﹤0.01% | 2428 |
|
|
2020
Q3 | $509K | Sell |
11,115
-2,539
| -19% | -$116K | ﹤0.01% | 2134 |
|
|
2020
Q2 | $686K | Sell |
13,654
-1,161
| -8% | -$58.3K | ﹤0.01% | 1974 |
|
|
2020
Q1 | $762K | Buy |
14,815
+1,811
| +14% | +$93.1K | ﹤0.01% | 1801 |
|
|
2019
Q4 | $803K | Buy |
13,004
+1,385
| +12% | +$85.6K | ﹤0.01% | 2030 |
|
|
2019
Q3 | $698K | Sell |
11,619
-1,385
| -11% | -$83.2K | ﹤0.01% | 2126 |
|
|
2019
Q2 | $1.1M | Buy |
13,004
+815
| +7% | +$68.8K | ﹤0.01% | 1840 |
|
|
2019
Q1 | $1.16M | Buy |
12,189
+3,469
| +40% | +$331K | ﹤0.01% | 1761 |
|
|
2018
Q4 | $618K | Sell |
8,720
-7
| -0.1% | -$496 | ﹤0.01% | 1907 |
|
|
2018
Q3 | $746K | Sell |
8,727
-2,088
| -19% | -$178K | ﹤0.01% | 1916 |
|
|
2018
Q2 | $1.25M | Buy |
10,815
+3,595
| +50% | +$417K | ﹤0.01% | 1718 |
|
|
2018
Q1 | $584K | Buy |
7,220
+3,120
| +76% | +$252K | ﹤0.01% | 1975 |
|
|
2017
Q4 | $241K | Buy |
+4,100
| New | +$241K | ﹤0.01% | 2215 |
|